ORIC Pharmaceuticals Inc. (ORIC)
NASDAQ: ORIC
· Real-Time Price · USD
13.30
-0.60 (-4.32%)
At close: Oct 16, 2025, 3:59 PM
13.57
2.03%
After-hours: Oct 16, 2025, 07:58 PM EDT
-4.32% (1D)
| Bid | 13 |
| Market Cap | 1.29B |
| Revenue (ttm) | 1.07M |
| Net Income (ttm) | -137.25M |
| EPS (ttm) | -1.89 |
| PE Ratio (ttm) | -7.04 |
| Forward PE | -7.74 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 14.21 |
| Volume | 1,382,732 |
| Avg. Volume (20D) | 1,293,153 |
| Open | 14.04 |
| Previous Close | 13.90 |
| Day's Range | 13.29 - 14.17 |
| 52-Week Range | 3.90 - 14.93 |
| Beta | 1.68 |
| Ex-Dividend Date | n/a |
About ORIC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORIC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ORIC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+33.5%
Oric Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
+3.29%
ORIC Pharmaceuticals shares are trading higher after the company announced preliminary efficacy and safety data from its ongoing Phase 1b trial of ORIC-944. Additionally, the company announced a $125 million private placement, which was priced at an 18% premium to its 10-day trailing volume-weighted average price.
